Rohto Ice - 75977-8143-1 - (hypromellose, tetrahydrozoline HCl, zinc sulfate)

Alphabetical Index


Drug Information of Rohto Ice

Product NDC: 75977-8143
Proprietary Name: Rohto Ice
Non Proprietary Name: hypromellose, tetrahydrozoline HCl, zinc sulfate
Active Ingredient(s): 2; .5; 2.5    mg/mL; mg/mL; mg/mL & nbsp;   hypromellose, tetrahydrozoline HCl, zinc sulfate
Administration Route(s): OPHTHALMIC
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Rohto Ice

Product NDC: 75977-8143
Labeler Name: Rohto-Mentholatum (Vietnam) Co. Ltd.
Product Type: HUMAN OTC DRUG
FDA Application Number: part349
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20110801

Package Information of Rohto Ice

Package NDC: 75977-8143-1
Package Description: 1 BOTTLE, WITH APPLICATOR in 1 CARTON (75977-8143-1) > 13 mL in 1 BOTTLE, WITH APPLICATOR

NDC Information of Rohto Ice

NDC Code 75977-8143-1
Proprietary Name Rohto Ice
Package Description 1 BOTTLE, WITH APPLICATOR in 1 CARTON (75977-8143-1) > 13 mL in 1 BOTTLE, WITH APPLICATOR
Product NDC 75977-8143
Product Type Name HUMAN OTC DRUG
Non Proprietary Name hypromellose, tetrahydrozoline HCl, zinc sulfate
Dosage Form Name LIQUID
Route Name OPHTHALMIC
Start Marketing Date 20110801
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Rohto-Mentholatum (Vietnam) Co. Ltd.
Substance Name HYPROMELLOSES; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE
Strength Number 2; .5; 2.5
Strength Unit mg/mL; mg/mL; mg/mL
Pharmaceutical Classes

Complete Information of Rohto Ice


General Information